Press release
PureTech Founded Entity Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia Therapies
April 25, 2023Business Services
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company, noted today that its Founded …
Brain scanning technology to be used for clinical psychedelics trials in pioneering London start-up partnership
April 25, 2023Business Services
London, UK: Commercial trials for psychedelics-assisted medical treatments will now have access to state-of-the-art brain scanning technology thanks to a …
Alchemab Therapeutics to present data profiling a novel antibody to Huntingtin Exon 1 at the CHDI Annual Huntington’s Disease Therapeutics Conference
April 25, 2023Business Services
Cambridge, UK, April 25, 2023 – Alchemab Therapeutics, an antibody discovery company identifying naturally occurring antibodies from individuals resilient to …
National Institute for Health and Care Excellence recommends Darzalex® (daratumumab) with bortezomib and dexamethasone for routine use on the NHS as treatment for multiple myeloma
April 24, 2023Business Services
High Wycombe, 24 April 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson are pleased to announce that the …
Sphere Fluidics begins work with partners on 3DSecret program to investigate mechanisms of metastasis in cancer
April 24, 2023Business Services
Cambridge, UK, 24th April 2023: Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, …
Incyte Announces European Commission Approval of Opzelura® (ruxolitinib) Cream for the Treatment of Non-Segmental Vitiligo with Facial Involvement in Adults and Adolescents
April 24, 2023Business Services
WILMINGTON, Del. – April 20, 2023 – Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has granted a marketing …
Janssen Marks First Approval Worldwide for AKEEGA® (Niraparib and Abiraterone Acetate Dual Action Tablet) with EC Authorisation for the Treatment of Patients with Metastatic Castration Resistant Prostate Cancer with BRCA1/2 Mutations
April 24, 2023Business Services
BEERSE, Belgium, 21 April 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the European Commission …
NICE gives green light to ibrutinib plus venetoclax as first-line treatment option for chronic lymphocytic leukaemia
April 24, 2023Business Services
High Wycombe, 21 April 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson is pleased to announce that the …
Breye Therapeutics Strengthens Management Team and Board
April 20, 2023Business Services
Copenhagen, Denmark, 20 April 2023 – Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing novel oral therapies for retinal …
Elsevier launches EmBiology to deliver the unparalleled insights into biological activities that accelerate drug discovery
April 19, 2023Business Services
New York, April 19, 2023 – Elsevier, a leader in global information analytics, has launched EmBiology, a research tool that …
Veeva MedTech Clinical Trials Report Signals Significant Opportunity to Improve Data Delivery and Quality
April 19, 2023Business Services
BARCELONA, Spain — 19 Apr. 2023 — Veeva Systems (NYSE: VEEV) today released its first-ever report examining global trends in …
Growth in global demand for pure medical cannabis sees Lesotho-based cultivator and manufacturer expand its production
April 19, 2023Business Services
19 April 2023, Maseru – Licensed cultivator and manufacturer of medical-grade cannabis extracts and products,
Revolo Biotherapeutics Announces Positive Topline Data from Phase 2a Trial of ‘1104 in Adults with Active Eosinophilic Esophagitis
April 19, 2023Business Services
NEW ORLEANS and CAMBRIDGE, UK, April 19 2023 – Revolo Biotherapeutics (“Revolo” or the “Company”), a company developing therapies that …
Oxford BioTherapeutics announces Phase 1b trial in collaboration with GORTEC to investigate OBT076 in Adenoid Cystic Carcinoma (ACC) of the head and neck
April 19, 2023Business Services
Oxford, UK and San Jose, Calif., 19 April 2023 – Oxford BioTherapeutics Ltd.
OWEN MUMFORD WINS DISTINCTION IN RED DOT AWARD (PRODUCT DESIGN 2023) FOR AIDAPTUS® AUTO-INJECTOR
April 18, 2023Business Services
OXFORD, England, 18 April 2023 – Owen Mumford is proud to have been awarded a distinction in the prestigious Red …
Latest content
Acumentis CEO Herspiegel steps down as Burden assumes role
